Work

AB0448 Patient-reported outcomes following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomised controlled trial

Year: 2018

Type: article

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2018-eular.1838

Authors: J. Kremer, W. Rigby, N. Singer, C. Birchwood, D. Gill, W. Reiss, J. Best, J. Pei, M. Michalska

Institutions: Center for Rheumatology, Albany Medical College, Dartmouth College, MetroHealth, Case Western Reserve University, Genentech

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Regeneron Pharmaceuticals, Genentech, EMD Serono

OpenAlex ID: W2808094802

FWCI: 0.428

Cites: 1

Cited by: 3

Related to: 10